{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:24:26Z","timestamp":1789428266994,"version":"build-2803163510"},"reference-count":262,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012562","name":"Gansu University of Chinese Medicine","doi-asserted-by":"publisher","award":["202307"],"award-info":[{"award-number":["202307"]}],"id":[{"id":"10.13039\/501100012562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009590","name":"Gansu Education Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["24JRRA1026"],"award-info":[{"award-number":["24JRRA1026"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["24JRRA1018"],"award-info":[{"award-number":["24JRRA1018"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.intimp.2025.115876","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:01:40Z","timestamp":1763658100000},"page":"115876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"P2","title":["Amino acid transporter SLC7A11 functions in ferroptosis regulation and immune microenvironment in osteosarcoma"],"prefix":"10.1016","volume":"168","author":[{"given":"Xueru","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoshan","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyu","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115876_bb0005","article-title":"Osteosarcoma","volume":"21 Suppl 7","author":"Ritter","year":"2010","journal-title":"Ann Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000525183","article-title":"Osteosarcoma in the Thyroid Gland","volume":"85","author":"Ijeoma","year":"2023","journal-title":"ORL J Otorhinolaryngol Relat Spec."},{"issue":"13","key":"10.1016\/j.intimp.2025.115876_bb0015","first-page":"2124","article-title":"Bone tumours in European children and adolescents, 1978-1997","volume":"42","author":"Stiller","year":"2006","journal-title":"Report from the Automated Childhood Cancer Information System project, Eur J Cancer."},{"issue":"6","key":"10.1016\/j.intimp.2025.115876_bb0020","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0959-8049(01)00004-1","article-title":"Survival of children with bone sarcoma in Europe since 1978: results from the EUROCARE study","volume":"37","author":"Stiller","year":"2001","journal-title":"Eur J Cancer."},{"issue":"3","key":"10.1016\/j.intimp.2025.115876_bb0025","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.2002.20.3.776","article-title":"Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols","volume":"20","author":"Bielack","year":"2002","journal-title":"J Clin Oncol."},{"issue":"17","key":"10.1016\/j.intimp.2025.115876_bb0030","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1200\/JCO.2011.38.4420","article-title":"Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG\/OS-1","volume":"30","author":"Ferrari","year":"2012","journal-title":"J Clin Oncol."},{"issue":"23","key":"10.1016\/j.intimp.2025.115876_bb0035","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1200\/JCO.2013.54.4833","article-title":"Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial","volume":"32","author":"Le Deley","year":"2014","journal-title":"J Clin Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115876_bb0040","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1200\/JCO.2002.20.2.426","article-title":"Phase II\/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial","volume":"20","author":"Goorin","year":"2002","journal-title":"J Clin Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1200\/JCO.2001.19.1.171","article-title":"Carboplatin\/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial","volume":"19","author":"Meyer","year":"2001","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.intimp.2025.115876_bb0050","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12885-016-2312-3","article-title":"Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone","volume":"16","author":"Palmerini","year":"2016","journal-title":"BMC Cancer."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1470-2045(14)71136-2","article-title":"Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial","volume":"16","author":"Grignani","year":"2015","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0060","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S1470-2045(18)30742-3","article-title":"Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study","volume":"20","author":"Duffaud","year":"2019","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1200\/JCO.2002.20.1.189","article-title":"High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases","volume":"20","author":"Anderson","year":"2002","journal-title":"J Clin Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0070","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ocl.2015.08.022","article-title":"Update on Survival in Osteosarcoma","volume":"47","author":"Anderson","year":"2016","journal-title":"Orthop Clin North Am."},{"issue":"3","key":"10.1016\/j.intimp.2025.115876_bb0075","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/jor.24227","article-title":"Targeting mutant TP53 as a potential therapeutic strategy for the treatment of osteosarcoma","volume":"37","author":"Tang","year":"2019","journal-title":"J Orthop Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.115876_bb0080","first-page":"347","article-title":"Evaluation of Cytotoxic and Antimicrobial Activities of Methanolic Extracts from Cystoseira foeniculacea and Sargassum vulgare","volume":"10","author":"Yaman","year":"2025","journal-title":"Advances in Biology & Earth Sciences."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-4889(82)90017-9","article-title":"Adaptive enhancement of cystine and glutamate uptake in human diploid fibroblasts in culture","volume":"721","author":"Bannai","year":"1982","journal-title":"Biochim Biophys Acta."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbrc.2009.10.168","article-title":"Cancer cells release glutamate via the cystine\/glutamate antiporter","volume":"391","author":"Sharma","year":"2010","journal-title":"Biochem Biophys Res Commun."},{"issue":"34","key":"10.1016\/j.intimp.2025.115876_bb0095","doi-asserted-by":"crossref","first-page":"14240","DOI":"10.1074\/jbc.M117.798405","article-title":"The glutamate\/cystine antiporter SLC7A11\/xCT enhances cancer cell dependency on glucose by exporting glutamate","volume":"292","author":"Koppula","year":"2017","journal-title":"J Biol Chem."},{"issue":"5","key":"10.1016\/j.intimp.2025.115876_bb0100","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.115876_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110602","article-title":"Gambogenic acid induces cell death in human osteosarcoma through altering iron metabolism, disturbing the redox balance, and activating the P53 signaling pathway","volume":"382","author":"Liu","year":"2023","journal-title":"Chem Biol Interact."},{"issue":"2","key":"10.1016\/j.intimp.2025.115876_bb0110","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1248\/bpb.b17-00672","article-title":"Bavachin Induces Apoptosis through Mitochondrial Regulated ER Stress Pathway in HepG2 Cells","volume":"41","author":"Yang","year":"2018","journal-title":"Biol Pharm Bull."},{"key":"10.1016\/j.intimp.2025.115876_bb0115","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02523","article-title":"Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"3","author":"Dixon","year":"2014","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.intimp.2025.115876_bb0120","first-page":"289","article-title":"Toxic Elements (As3+, Pb2+, Hg2+, Cd2+) In Wastewater: A Case Study On Environmental Threats And Health Risks","volume":"10","author":"Tumur","year":"2025","journal-title":"Advances in Biology & Earth Sciences."},{"issue":"4","key":"10.1016\/j.intimp.2025.115876_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040976","article-title":"The Osteosarcoma Microenvironment: A Complex But Targetable Ecosystem","volume":"9","author":"Corre","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13287-018-0780-x","article-title":"Mesenchymal stem cells in the osteosarcoma microenvironment: their biological properties, influence on tumor growth, and therapeutic implications","volume":"9","author":"Zheng","year":"2018","journal-title":"Stem Cell Res Ther."},{"issue":"2","key":"10.1016\/j.intimp.2025.115876_bb0135","first-page":"245","article-title":"Harnessing Adrenergic Receptor Pathways in Gliomas: From Tumor Biology to Targeted Therapies","volume":"10","author":"Gareev","year":"2025","journal-title":"Advances in Biology & Earth Sciences."},{"issue":"19","key":"10.1016\/j.intimp.2025.115876_bb0140","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1021\/acs.jmedchem.9b00644","article-title":"Natural Product Albiziabioside A Conjugated with Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate To Induce Apoptosis-Ferroptosis-M2-TAMs Polarization for Combined Cancer Therapy","volume":"62","author":"Wei","year":"2019","journal-title":"J Med Chem."},{"issue":"3","key":"10.1016\/j.intimp.2025.115876_bb0145","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1021\/acsnano.9b09426","article-title":"Enhanced Ferroptosis by Oxygen-Boosted Phototherapy Based on a 2-in-1 Nanoplatform of Ferrous Hemoglobin for Tumor Synergistic Therapy","volume":"14","author":"Xu","year":"2020","journal-title":"ACS Nano."},{"issue":"1-2","key":"10.1016\/j.intimp.2025.115876_bb0150","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.intimp.2025.115876_bb0155","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2019.03.032","article-title":"Selenium Drives a Transcriptional Adaptive Program to Block Ferroptosis and Treat Stroke","volume":"177","author":"Alim","year":"2019","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.intimp.2025.115876_bb0160","doi-asserted-by":"crossref","first-page":"14750","DOI":"10.1074\/jbc.M114.551994","article-title":"Selective up-regulation of human selenoproteins in response to oxidative stress","volume":"289","author":"Touat-Hamici","year":"2014","journal-title":"J Biol Chem."},{"key":"10.1016\/j.intimp.2025.115876_bb0165","article-title":"Ferroptosis and Cancer: Complex Relationship and Potential Application of Exosomes","volume":"9","author":"Wu","year":"2021","journal-title":"Front Cell Dev Biol."},{"issue":"36","key":"10.1016\/j.intimp.2025.115876_bb0170","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1038\/s41388-018-0307-z","article-title":"xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression","volume":"37","author":"Ji","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2025.115876_bb0175","article-title":"Novel Therapeutic Savior for Osteosarcoma: The Endorsement of Ferroptosis","volume":"12","author":"Qiu","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.intimp.2025.115876_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105466","article-title":"Ferroptosis and its emerging roles in cardiovascular diseases","volume":"166","author":"Li","year":"2021","journal-title":"Pharmacol Res."},{"issue":"8","key":"10.1016\/j.intimp.2025.115876_bb0185","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"issue":"1-2","key":"10.1016\/j.intimp.2025.115876_bb0190","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mam.2008.05.005","article-title":"Regulation of glutathione synthesis","volume":"30","author":"Lu","year":"2009","journal-title":"Mol Aspects Med."},{"key":"10.1016\/j.intimp.2025.115876_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103066","article-title":"Hydrogen sulfide protects cardiomyocytes from doxorubicin-induced ferroptosis through the SLC7A11\/GSH\/GPx4 pathway by Keap1 S-sulfhydration and Nrf2 activation","volume":"70","author":"Zhang","year":"2024","journal-title":"Redox Biol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115876_bb0200","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/WNR.0000000000001679","article-title":"SIRT2 inhibition exacerbates p53-mediated ferroptosis in mice following experimental traumatic brain injury","volume":"32","author":"Gao","year":"2021","journal-title":"Neuroreport"},{"issue":"17","key":"10.1016\/j.intimp.2025.115876_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174284","article-title":"TP53 in Biology and Treatment of Osteosarcoma","volume":"13","author":"Synoradzki","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"5","key":"10.1016\/j.intimp.2025.115876_bb0210","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41418-022-00943-y","article-title":"p53 in ferroptosis regulation: the new weapon for the old guardian","volume":"29","author":"Liu","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2025.115876_bb0215","article-title":"Scar-reducing effects of gambogenic acid on skin wounds in rabbit ears","volume":"90","author":"Jun","year":"2021","journal-title":"Int Immunopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115876_bb0220","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1021\/acs.molpharmaceut.1c00030","article-title":"Oral Delivery of Gambogenic Acid by Functional Polydopamine Nanoparticles for Targeted Tumor Therapy","volume":"18","author":"Wang","year":"2021","journal-title":"Mol Pharm."},{"issue":"12","key":"10.1016\/j.intimp.2025.115876_bb0225","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.7314\/APJCP.2013.14.12.7601","article-title":"Gambogenic acid induction of apoptosis in a breast cancer cell line","volume":"14","author":"Zhou","year":"2013","journal-title":"Asian Pac J Cancer Prev."},{"issue":"21","key":"10.1016\/j.intimp.2025.115876_bb0230","first-page":"4311","article-title":"Mechanism of gambogenic acid in resisting angiogenesis of lung cancer in vitro","volume":"43","author":"Cheng","year":"2018","journal-title":"Zhongguo Zhong Yao Za Zhi."},{"issue":"2","key":"10.1016\/j.intimp.2025.115876_bb0235","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.etap.2011.12.006","article-title":"Gambogenic acid induced mitochondrial-dependent apoptosis and referred to phospho-Erk1\/2 and phospho-p38 MAPK in human hepatoma HepG2 cells","volume":"33","author":"Yan","year":"2012","journal-title":"Environ Toxicol Pharmacol."},{"key":"10.1016\/j.intimp.2025.115876_bb0240","article-title":"Gambogenic Acid Induces Endoplasmic Reticulum Stress in Colorectal Cancer via the Aurora A Pathway","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev Biol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115876_bb0245","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3892\/mmr.2020.10909","article-title":"Gambogenic acid exerts anticancer effects in cisplatin-resistant non-small cell lung cancer cells","volume":"21","author":"Shen","year":"2020","journal-title":"Mol Med Rep."},{"key":"10.1016\/j.intimp.2025.115876_bb0250","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3389\/fphar.2019.01427","article-title":"Bavachin Protects Human Aortic Smooth Muscle Cells Against \u03b2-Glycerophosphate-Mediated Vascular Calcification and Apoptosis via Activation of mTOR-Dependent Autophagy and Suppression of \u03b2-Catenin Signaling","volume":"10","author":"He","year":"2019","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.intimp.2025.115876_bb0255","doi-asserted-by":"crossref","first-page":"1783485","DOI":"10.1155\/2021\/1783485","article-title":"Bavachin Induces Ferroptosis through the STAT3\/P53\/SLC7A11 Axis in Osteosarcoma Cells","volume":"2021","author":"Luo","year":"2021","journal-title":"Oxid Med Cell Longev."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0260","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/s42003-023-05477-8","article-title":"Cholesterol mediated ferroptosis suppression reveals essential roles of Coenzyme Q and squalene","volume":"6","author":"Sun","year":"2023","journal-title":"Commun Biol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115876_bb0265","article-title":"Ferroptosis and Its Multifaceted Role in Cancer","volume":"11","author":"Chen","year":"2022","journal-title":"Mechanisms and Therapeutic Approach, Antioxidants (Basel)."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0270","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12974-024-03099-3","article-title":"Oroxin A alleviates early brain injury after subarachnoid hemorrhage by regulating ferroptosis and neuroinflammation","volume":"21","author":"Chen","year":"2024","journal-title":"J Neuroinflammation."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0275","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.gendis.2022.12.003","article-title":"CD36 promotes tubular ferroptosis by regulating the ubiquitination of FSP1 in acute kidney injury","volume":"11","author":"Ma","year":"2024","journal-title":"Genes Dis."},{"issue":"1-3","key":"10.1016\/j.intimp.2025.115876_bb0280","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-5793(02)03049-1","article-title":"A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF)","volume":"524","author":"Ohiro","year":"2002","journal-title":"FEBS Lett."},{"issue":"28","key":"10.1016\/j.intimp.2025.115876_bb0285","doi-asserted-by":"crossref","first-page":"25617","DOI":"10.1074\/jbc.M202285200","article-title":"AMID, an apoptosis-inducing factor-homologous mitochondrion-associated protein, induces caspase-independent apoptosis","volume":"277","author":"Wu","year":"2002","journal-title":"J Biol Chem."},{"issue":"41","key":"10.1016\/j.intimp.2025.115876_bb0290","doi-asserted-by":"crossref","first-page":"30331","DOI":"10.1074\/jbc.M703713200","article-title":"DNA binding suppresses human AIF-M2 activity and provides a connection between redox chemistry, reactive oxygen species, and apoptosis","volume":"282","author":"Gong","year":"2007","journal-title":"J Biol Chem."},{"issue":"5","key":"10.1016\/j.intimp.2025.115876_bb0295","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41419-022-04924-4","article-title":"Involvement of FSP1-CoQ(10)-NADH and GSH-GPx-4 pathways in retinal pigment epithelium ferroptosis","volume":"13","author":"Yang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0300","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1186\/s13018-023-04448-3","article-title":"Prevention and treatment of osteoporosis with natural products: Regulatory mechanism based on cell ferroptosis","volume":"18","author":"Yang","year":"2023","journal-title":"J Orthop Surg Res."},{"key":"10.1016\/j.intimp.2025.115876_bb0305","article-title":"Discovering the Potential Value of Coenzyme Q10 in Oxidative Stress: Enlightenment From a Synthesis of Clinical Evidence Based on Various Population","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115876_bb0310","doi-asserted-by":"crossref","first-page":"185","DOI":"10.14797\/mdcj-15-3-185","article-title":"Coenzyme Q(10)","volume":"15","author":"Raizner","year":"2019","journal-title":"Methodist Debakey Cardiovasc J."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0315","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cmet.2019.12.007","article-title":"The Antioxidant Role of Non-mitochondrial CoQ10: Mystery Solved!","volume":"31","author":"Santoro","year":"2020","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.intimp.2025.115876_bb0320","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.molmed.2023.05.013","article-title":"FSP1: a key regulator of ferroptosis","volume":"29","author":"Li","year":"2023","journal-title":"Trends Mol Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0325","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41420-024-01854-2","article-title":"FSP1 is a predictive biomarker of osteosarcoma cells' susceptibility to ferroptotic cell death and a potential therapeutic target","volume":"10","author":"Panczyszyn","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.intimp.2025.115876_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110100","article-title":"Nrf2\/FSP1\/CoQ10 axis-mediated ferroptosis is involved in sodium aescinate-induced nephrotoxicity","volume":"759","author":"Zhu","year":"2024","journal-title":"Arch Biochem Biophys."},{"issue":"7784","key":"10.1016\/j.intimp.2025.115876_bb0335","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.intimp.2025.115876_bb0340","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1080\/15548627.2020.1714209","article-title":"Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein","volume":"16","author":"Dai","year":"2020","journal-title":"Autophagy"},{"issue":"10","key":"10.1016\/j.intimp.2025.115876_bb0345","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.jid.2017.05.019","article-title":"The Nrf2\/GCH1\/BH4 Axis Ameliorates Radiation-Induced Skin Injury by Modulating the ROS Cascade","volume":"137","author":"Xue","year":"2017","journal-title":"J Invest Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0350","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","article-title":"GTP Cyclohydrolase 1\/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling","volume":"6","author":"Kraft","year":"2020","journal-title":"ACS Cent Sci."},{"key":"10.1016\/j.intimp.2025.115876_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.810327","article-title":"Blockade of GCH1\/BH4 Axis Activates Ferritinophagy to Mitigate the Resistance of Colorectal Cancer to Erastin-Induced Ferroptosis","volume":"10","author":"Hu","year":"2022","journal-title":"Front Cell Dev Biol."},{"issue":"39","key":"10.1016\/j.intimp.2025.115876_bb0360","doi-asserted-by":"crossref","first-page":"40677","DOI":"10.1074\/jbc.M405370200","article-title":"The mechanism of potent GTP cyclohydrolase I inhibition by 2,4-diamino-6-hydroxypyrimidine: requirement of the GTP cyclohydrolase I feedback regulatory protein","volume":"279","author":"Kolinsky","year":"2004","journal-title":"J Biol Chem."},{"issue":"6","key":"10.1016\/j.intimp.2025.115876_bb0365","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/HYPERTENSIONAHA.108.123422","article-title":"Metallothionein abrogates GTP cyclohydrolase I inhibition-induced cardiac contractile and morphological defects: role of mitochondrial biogenesis","volume":"53","author":"Ceylan-Isik","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.intimp.2025.115876_bb0370","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1615758","article-title":"Cytotoxic effects of artemisia annua L. and pure artemisinin on the D-17 canine osteosarcoma cell line","volume":"2019","author":"Isani","year":"2019","journal-title":"Oxid Med Cell Longev."},{"issue":"18","key":"10.1016\/j.intimp.2025.115876_bb0375","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700965","article-title":"Isothiocyanates: Translating the Power of Plants to People","volume":"62","author":"Palliyaguru","year":"2018","journal-title":"Mol Nutr Food Res."},{"key":"10.1016\/j.intimp.2025.115876_bb0380","first-page":"5021983","article-title":"\u03b2-Phenethyl Isothiocyanate Induces Cell Death in Human Osteosarcoma through Altering Iron Metabolism","volume":"2020","author":"Lv","year":"2020","journal-title":"Disturbing the Redox Balance, and Activating the MAPK Signaling Pathway, Oxid Med Cell Longev."},{"issue":"8","key":"10.1016\/j.intimp.2025.115876_bb0385","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/s41401-020-0376-8","article-title":"PEITC triggers multiple forms of cell death by GSH-iron-ROS regulation in K7M2 murine osteosarcoma cells","volume":"41","author":"Lv","year":"2020","journal-title":"Acta Pharmacol Sin."},{"key":"10.1016\/j.intimp.2025.115876_bb0390","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbrc.2021.02.137","article-title":"KDM4A-mediated histone demethylation of SLC7A11 inhibits cell ferroptosis in osteosarcoma","volume":"550","author":"Chen","year":"2021","journal-title":"Biochem Biophys Res Commun."},{"key":"10.1016\/j.intimp.2025.115876_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.515051","article-title":"NDUFA4L2 Regulated by HIF-1\u03b1 Promotes Metastasis and Epithelial-Mesenchymal Transition of Osteosarcoma Cells Through Inhibiting ROS Production","volume":"8","author":"Xu","year":"2020","journal-title":"Front Cell Dev Biol."},{"issue":"11-12","key":"10.1016\/j.intimp.2025.115876_bb0400","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/10715762.2021.2024816","article-title":"MicroRNA-1287-5p promotes ferroptosis of osteosarcoma cells through inhibiting GPX4","volume":"55","author":"Xu","year":"2021","journal-title":"Free Radic Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0405","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12943-023-01804-z","article-title":"Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1","volume":"22","author":"Jiang","year":"2023","journal-title":"Mol Cancer."},{"issue":"4","key":"10.1016\/j.intimp.2025.115876_bb0410","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1349-7006.2011.02199.x","article-title":"Zinc finger E-box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial-to-mesenchymal transition","volume":"103","author":"Liu","year":"2012","journal-title":"Cancer Sci."},{"issue":"16","key":"10.1016\/j.intimp.2025.115876_bb0415","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1007\/s00018-015-1918-y","article-title":"Bone microenvironment signals in osteosarcoma development","volume":"72","author":"Alfranca","year":"2015","journal-title":"Cell Mol Life Sci."},{"key":"10.1016\/j.intimp.2025.115876_bb0420","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-3-030-59038-3_20","article-title":"Sarcoma Tumor Microenvironment","volume":"1296","author":"Tsagozis","year":"2020","journal-title":"Adv Exp Med Biol."},{"key":"10.1016\/j.intimp.2025.115876_bb0425","article-title":"Immune Microenvironment in Osteosarcoma: Components","volume":"13","author":"Zhu","year":"2022","journal-title":"Therapeutic Strategies and Clinical Applications, Front Immunol."},{"issue":"19","key":"10.1016\/j.intimp.2025.115876_bb0430","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202200195","article-title":"Engineering Novel 3D Models to Recreate High-Grade Osteosarcoma and its Immune and Extracellular Matrix Microenvironment","volume":"11","author":"Pierrevelcin","year":"2022","journal-title":"Adv Healthc Mater."},{"issue":"9","key":"10.1016\/j.intimp.2025.115876_bb0435","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S1470-2045(22)00392-8","article-title":"Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial","volume":"23","author":"Somaiah","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.intimp.2025.115876_bb0440","first-page":"107","article-title":"Remodeling tumor immunosuppressive microenvironment via a novel bioactive nanovaccines potentiates the efficacy of cancer immunotherapy","volume":"16","author":"Xie","year":"2022","journal-title":"Bioact Mater."},{"issue":"2","key":"10.1016\/j.intimp.2025.115876_bb0445","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00262-022-03255-9","article-title":"A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment","volume":"72","author":"Kuo","year":"2023","journal-title":"Cancer Immunol Immunother."},{"key":"10.1016\/j.intimp.2025.115876_bb0450","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.intimp.2016.05.016","article-title":"The role of CTLA-4 and PD-1 in anti-tumor immune response and their potential efficacy against osteosarcoma","volume":"38","author":"Wang","year":"2016","journal-title":"Int Immunopharmacol."},{"issue":"17","key":"10.1016\/j.intimp.2025.115876_bb0455","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1158\/1078-0432.CCR-16-3186","article-title":"Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors","volume":"23","author":"Ratti","year":"2017","journal-title":"Clin Cancer Res."},{"issue":"8","key":"10.1016\/j.intimp.2025.115876_bb0460","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/ijc.33382","article-title":"Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent and in combination with checkpoint-inhibitor therapy in mouse models of osteosarcoma","volume":"148","author":"Hennessy","year":"2021","journal-title":"Int J Cancer."},{"key":"10.1016\/j.intimp.2025.115876_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2019.100221","article-title":"Advances in immune checkpoint inhibitors for bone sarcoma therapy","volume":"15","author":"Thanindratarn","year":"2019","journal-title":"J Bone Oncol."},{"issue":"21","key":"10.1016\/j.intimp.2025.115876_bb0470","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.1158\/1078-0432.CCR-18-4032","article-title":"Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations","volume":"25","author":"Suehara","year":"2019","journal-title":"Clin Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.115876_bb0475","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s13402-021-00598-w","article-title":"The role of tumor-associated macrophages in osteosarcoma progression - therapeutic implications","volume":"44","author":"Huang","year":"2021","journal-title":"Cell Oncol (Dordr)."},{"issue":"7","key":"10.1016\/j.intimp.2025.115876_bb0480","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1158\/2326-6066.CIR-16-0259","article-title":"All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages","volume":"5","author":"Zhou","year":"2017","journal-title":"Cancer Immunol Res."},{"issue":"8","key":"10.1016\/j.intimp.2025.115876_bb0485","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1158\/1078-0432.CCR-10-2047","article-title":"Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents","volume":"17","author":"Buddingh","year":"2011","journal-title":"Clin Cancer Res."},{"issue":"17","key":"10.1016\/j.intimp.2025.115876_bb0490","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.21037\/atm-20-3881","article-title":"Blocking the Notch signal transduction pathway promotes tumor growth in osteosarcoma by affecting polarization of TAM to M2 phenotype","volume":"8","author":"Ren","year":"2020","journal-title":"Ann Transl Med."},{"issue":"48","key":"10.1016\/j.intimp.2025.115876_bb0495","doi-asserted-by":"crossref","first-page":"78343","DOI":"10.18632\/oncotarget.13055","article-title":"Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma","volume":"7","author":"Dumars","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.intimp.2025.115876_bb0500","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/s41401-019-0262-4","article-title":"Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells","volume":"40","author":"Shao","year":"2019","journal-title":"Acta Pharmacol Sin."},{"issue":"7","key":"10.1016\/j.intimp.2025.115876_bb0505","doi-asserted-by":"crossref","first-page":"687","DOI":"10.18632\/oncotarget.27479","article-title":"Mifamurtide and TAM-like macrophages: effect on proliferation, migration and differentiation of osteosarcoma cells","volume":"11","author":"Punzo","year":"2020","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.intimp.2025.115876_bb0510","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1007\/s13277-014-2005-y","article-title":"Inhibition of macrophage polarization prohibits growth of human osteosarcoma","volume":"35","author":"Xiao","year":"2014","journal-title":"Tumour Biol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115876_bb0515","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/1535-7163.MCT-20-0591","article-title":"CSF1\/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment","volume":"20","author":"Fujiwara","year":"2021","journal-title":"Mol Cancer Ther."},{"key":"10.1016\/j.intimp.2025.115876_bb0520","doi-asserted-by":"crossref","first-page":"39862","DOI":"10.1038\/srep39862","article-title":"Prognostic value of inflammation-based scores in patients with osteosarcoma","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep."},{"key":"10.1016\/j.intimp.2025.115876_bb0525","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12957-016-0889-2","article-title":"Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma","volume":"14","author":"Xia","year":"2016","journal-title":"World J Surg Oncol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115876_bb0530","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/MPH.0000000000000911","article-title":"Pretreatment Neutrophil-to-Lymphocyte Ratio and Lymphocyte Recovery: Independent Prognostic Factors for Survival in Pediatric Sarcomas","volume":"39","author":"Vasquez","year":"2017","journal-title":"J Pediatr Hematol Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115876_bb0535","doi-asserted-by":"crossref","first-page":"489","DOI":"10.52312\/jdrs.2021.79775","article-title":"Diagnostic and prognostic role of neutrophil\/lymphocyte ratio, platelet\/lymphocyte ratio, and lymphocyte\/monocyte ratio in patients with osteosarcoma","volume":"32","author":"Yapar","year":"2021","journal-title":"Jt Dis Relat Surg."},{"issue":"4","key":"10.1016\/j.intimp.2025.115876_bb0540","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11040564","article-title":"Tumor-Associated Neutrophils in Cancer: Going Pro","volume":"11","author":"Wu","year":"2019","journal-title":"Cancers (Basel)."},{"issue":"2","key":"10.1016\/j.intimp.2025.115876_bb0545","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.intimp.2025.115876_bb0550","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fimmu.2012.00307","article-title":"PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular trap-like structures","volume":"3","author":"Leshner","year":"2012","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115876_bb0555","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \"N1\" versus \"N2\" TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell."},{"key":"10.1016\/j.intimp.2025.115876_bb0560","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.633607","article-title":"Development and Validation of a Hypoxia-Associated Prognostic Signature Related to Osteosarcoma Metastasis and Immune Infiltration","volume":"9","author":"Fu","year":"2021","journal-title":"Front Cell Dev Biol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115876_bb0565","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001772","article-title":"Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes","volume":"9","author":"Ligon","year":"2021","journal-title":"J Immunother Cancer."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0570","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00262-016-1925-3","article-title":"Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy","volume":"66","author":"Sundara","year":"2017","journal-title":"Cancer Immunol Immunother."},{"key":"10.1016\/j.intimp.2025.115876_bb0575","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.intimp.2016.01.023","article-title":"CD163(+) M2-type tumor-associated macrophage support the suppression of tumor-infiltrating T cells in osteosarcoma","volume":"34","author":"Han","year":"2016","journal-title":"Int Immunopharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115876_bb0580","first-page":"5197","article-title":"Extraskeletal osteosarcoma with partial spontaneous regression","volume":"29","author":"Matsuo","year":"2009","journal-title":"Anticancer Res."},{"issue":"8","key":"10.1016\/j.intimp.2025.115876_bb0585","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/cmi.2017.35","article-title":"B cell regulation in cancer and anti-tumor immunity","volume":"14","author":"Sarvaria","year":"2017","journal-title":"Cell Mol Immunol."},{"issue":"16","key":"10.1016\/j.intimp.2025.115876_bb0590","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1002\/cam4.4117","article-title":"A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma","volume":"10","author":"Yang","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.intimp.2025.115876_bb0595","article-title":"Application of Immune Infiltration Signature and Machine Learning Model in the Differential Diagnosis and Prognosis of Bone-Related Malignancies","volume":"9","author":"Li","year":"2021","journal-title":"Front Cell Dev Biol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115876_bb0600","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","article-title":"Exploring the NK cell platform for cancer immunotherapy","volume":"18","author":"Myers","year":"2021","journal-title":"Nat Rev Clin Oncol."},{"key":"10.1016\/j.intimp.2025.115876_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.771737","article-title":"Natural Killer and T Cell Infiltration in Canine Osteosarcoma: Clinical Implications and Translational Relevance","volume":"8","author":"Razmara","year":"2021","journal-title":"Front Vet Sci."},{"issue":"8","key":"10.1016\/j.intimp.2025.115876_bb0610","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1158\/2767-9764.CRC-22-0505","article-title":"Natural Killer Cell Activation by Ubiquitin-specific Protease 6 Mediates Tumor Suppression in Ewing Sarcoma","volume":"3","author":"Jain","year":"2023","journal-title":"Cancer Res Commun."},{"issue":"8","key":"10.1016\/j.intimp.2025.115876_bb0615","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1158\/0008-5472.CAN-20-1458","article-title":"Ubiquitin-Specific Protease 6 Functions as a Tumor Suppressor in Ewing Sarcoma through Immune Activation","volume":"81","author":"Henrich","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2025.115876_bb0620","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.672361","article-title":"Adoptive Natural Killer Cell Immunotherapy for Canine Osteosarcoma","volume":"8","author":"Kisseberth","year":"2021","journal-title":"Front Vet Sci."},{"issue":"6","key":"10.1016\/j.intimp.2025.115876_bb0625","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3892\/or_00001026","article-title":"Sodium valproate, a histone deacetylase inhibitor, augments the expression of cell-surface NKG2D ligands, MICA\/B, without increasing their soluble forms to enhance susceptibility of human osteosarcoma cells to NK cell-mediated cytotoxicity","volume":"24","author":"Yamanegi","year":"2010","journal-title":"Oncol Rep."},{"issue":"4","key":"10.1016\/j.intimp.2025.115876_bb0630","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00262-010-0965-3","article-title":"Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells","volume":"60","author":"Buddingh","year":"2011","journal-title":"Cancer Immunol Immunother."},{"key":"10.1016\/j.intimp.2025.115876_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215690","article-title":"Blocking FSTL1 boosts NK immunity in treatment of osteosarcoma","volume":"537","author":"Ogiwara","year":"2022","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.intimp.2025.115876_bb0640","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1172\/JCI70559","article-title":"Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation","volume":"123","author":"Kansara","year":"2013","journal-title":"J Clin Invest."},{"issue":"7","key":"10.1016\/j.intimp.2025.115876_bb0645","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1476-5381.2012.02108.x","article-title":"Invariant NKT cells increase drug-induced osteosarcoma cell death","volume":"167","author":"Fallarini","year":"2012","journal-title":"Br J Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0650","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: an update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"issue":"10","key":"10.1016\/j.intimp.2025.115876_bb0655","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13102367","article-title":"Data-Driven Mathematical Model of Osteosarcoma","volume":"13","author":"Le","year":"2021","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.intimp.2025.115876_bb0660","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13569-016-0053-3","article-title":"Dendritic and mast cell involvement in the inflammatory response to primary malignant bone tumours","volume":"6","author":"Inagaki","year":"2016","journal-title":"Clin Sarcoma Res."},{"key":"10.1016\/j.intimp.2025.115876_bb0665","article-title":"Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Mol Biosci."},{"issue":"11","key":"10.1016\/j.intimp.2025.115876_bb0670","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1158\/2159-8290.CD-19-0154","article-title":"Infiltrating Myeloid Cells Drive Osteosarcoma Progression via GRM4 Regulation of IL23","volume":"9","author":"Kansara","year":"2019","journal-title":"Cancer Discov."},{"issue":"11","key":"10.1016\/j.intimp.2025.115876_bb0675","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1158\/2159-8290.CD-19-0994","article-title":"Dendritic Cells Drive Osteosarcomagenesis through Newly Identified Oncogene and Tumor Suppressor","volume":"9","author":"Jones","year":"2019","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.intimp.2025.115876_bb0680","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3892\/etm.2016.3368","article-title":"Capsaicin induces immunogenic cell death in human osteosarcoma cells","volume":"12","author":"Jin","year":"2016","journal-title":"Exp Ther Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0685","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1038\/s41467-020-20059-6","article-title":"Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat Commun."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0690","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000474","article-title":"Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103(+) conventional dendritic cells","volume":"8","author":"Zhou","year":"2020","journal-title":"J Immunother Cancer."},{"issue":"3","key":"10.1016\/j.intimp.2025.115876_bb0695","first-page":"693","article-title":"Osteosarcoma: current status of immunotherapy and future trends (Review)","volume":"15","author":"Mori","year":"2006","journal-title":"Oncol Rep."},{"issue":"8","key":"10.1016\/j.intimp.2025.115876_bb0700","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s11999-012-2299-2","article-title":"Anti-TGF-\u03b2 antibody combined with dendritic cells produce antitumor effects in osteosarcoma","volume":"470","author":"Kawano","year":"2012","journal-title":"Clin Orthop Relat Res."},{"key":"10.1016\/j.intimp.2025.115876_bb0705","doi-asserted-by":"crossref","first-page":"30093","DOI":"10.1038\/srep30093","article-title":"Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma","volume":"6","author":"Koirala","year":"2016","journal-title":"Sci Rep."},{"issue":"2","key":"10.1016\/j.intimp.2025.115876_bb0710","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.3934\/mbe.2021098","article-title":"Immune classification of osteosarcoma","volume":"18","author":"Le","year":"2021","journal-title":"Math Biosci Eng."},{"issue":"5","key":"10.1016\/j.intimp.2025.115876_bb0715","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1074\/jbc.274.5.3009","article-title":"4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer","volume":"274","author":"Nakamura","year":"1999","journal-title":"J Biol Chem."},{"issue":"17","key":"10.1016\/j.intimp.2025.115876_bb0720","doi-asserted-by":"crossref","first-page":"11455","DOI":"10.1074\/jbc.274.17.11455","article-title":"Cloning and expression of a plasma membrane cystine\/glutamate exchange transporter composed of two distinct proteins","volume":"274","author":"Sato","year":"1999","journal-title":"J Biol Chem."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0725","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00726-011-0867-5","article-title":"The oxidative stress-inducible cystine\/glutamate antiporter, system x (c) (-) : cystine supplier and beyond","volume":"42","author":"Conrad","year":"2012","journal-title":"Amino Acids."},{"issue":"5","key":"10.1016\/j.intimp.2025.115876_bb0730","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/S0021-9258(17)35926-4","article-title":"Exchange of cystine and glutamate across plasma membrane of human fibroblasts","volume":"261","author":"Bannai","year":"1986","journal-title":"J Biol Chem."},{"key":"10.1016\/j.intimp.2025.115876_bb0735","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.freeradbiomed.2020.07.012","article-title":"Astrocyte hepcidin ameliorates neuronal loss through attenuating brain iron deposition and oxidative stress in APP\/PS1 mice","volume":"158","author":"Xu","year":"2020","journal-title":"Free Radic Biol Med."},{"issue":"18","key":"10.1016\/j.intimp.2025.115876_bb0740","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1080\/15384101.2015.1068479","article-title":"Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses","volume":"14","author":"Jiang","year":"2015","journal-title":"Cell Cycle."},{"issue":"10","key":"10.1016\/j.intimp.2025.115876_bb0745","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","article-title":"BAP1 links metabolic regulation of ferroptosis to tumour suppression","volume":"20","author":"Zhang","year":"2018","journal-title":"Nat Cell Biol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115876_bb0750","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","article-title":"Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11","volume":"9","author":"Lang","year":"2019","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0755","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","article-title":"NRF2 and the Hallmarks of Cancer","volume":"34","author":"Rojo de la Vega","year":"2018","journal-title":"Cancer Cell."},{"issue":"4","key":"10.1016\/j.intimp.2025.115876_bb0760","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrm3545","article-title":"Emerging roles for chromatin as a signal integration and storage platform","volume":"14","author":"Badeaux","year":"2013","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115876_bb0765","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCRESAHA.119.316007","article-title":"The Calcineurin-TFEB-p62 Pathway Mediates the Activation of Cardiac Macroautophagy by Proteasomal Malfunction","volume":"127","author":"Pan","year":"2020","journal-title":"Circ Res."},{"issue":"8","key":"10.1016\/j.intimp.2025.115876_bb0770","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1158\/0008-5472.CAN-18-3037","article-title":"The Deubiquitylase OTUB1 Mediates Ferroptosis via Stabilization of SLC7A11","volume":"79","author":"Liu","year":"2019","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.115876_bb0775","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2011.01.038","article-title":"CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth","volume":"19","author":"Ishimoto","year":"2011","journal-title":"Cancer Cell."},{"key":"10.1016\/j.intimp.2025.115876_bb0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103460","article-title":"Targeting p62 by sulforaphane promotes autolysosomal degradation of SLC7A11, inducing ferroptosis for osteosarcoma treatment","volume":"79","author":"Zou","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.intimp.2025.115876_bb0785","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbrc.2021.06.036","article-title":"Tirapazamine suppress osteosarcoma cells in part through SLC7A11 mediated ferroptosis","volume":"567","author":"Shi","year":"2021","journal-title":"Biochem Biophys Res Commun."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0790","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12885-024-11951-1","article-title":"Oridonin-induced ferroptosis and apoptosis: a dual approach to suppress the growth of osteosarcoma cells","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Cancer."},{"key":"10.1016\/j.intimp.2025.115876_bb0795","article-title":"Intra-Tumoral Expression of SLC7A11 Is Associated with Immune Microenvironment","volume":"12","author":"He","year":"2021","journal-title":"Drug Resistance, and Prognosis in Cancers: A Pan-Cancer Analysis, Front Genet."},{"issue":"9","key":"10.1016\/j.intimp.2025.115876_bb0800","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.21037\/tcr-24-1182","article-title":"Disulfidptosis-related gene SLC7A11 predicts prognosis and indicates tumor immune infiltration in lung adenocarcinoma","volume":"13","author":"Zhu","year":"2024","journal-title":"Transl Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0805","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12935-023-03091-6","article-title":"Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies","volume":"23","author":"Liu","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.intimp.2025.115876_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156960","article-title":"Formononetin enhances cisplatin chemotherapy sensitivity in osteosarcoma by inducing ferroptosis and reconstructing the immune microenvironment","volume":"145","author":"Liu","year":"2025","journal-title":"Phytomedicine"},{"issue":"9","key":"10.1016\/j.intimp.2025.115876_bb0815","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031435","article-title":"KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer","volume":"8","author":"Waters","year":"2018","journal-title":"Cold Spring Harb Perspect Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0820","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40425-019-0511-6","article-title":"Cancer-cell-secreted CXCL11 promoted CD8(+) T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC","volume":"7","author":"Gao","year":"2019","journal-title":"J Immunother Cancer."},{"issue":"5","key":"10.1016\/j.intimp.2025.115876_bb0825","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control","volume":"172","author":"B\u00f6ttcher","year":"2018","journal-title":"Cell"},{"issue":"7759","key":"10.1016\/j.intimp.2025.115876_bb0830","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41586-019-1215-2","article-title":"Targeting the CBM complex causes T(reg) cells to prime tumours for immune checkpoint therapy","volume":"570","author":"Di Pilato","year":"2019","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.intimp.2025.115876_bb0835","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat Biomed Eng."},{"issue":"12","key":"10.1016\/j.intimp.2025.115876_bb0840","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1172\/JCI126199","article-title":"Endogenous T cells prevent tumor immune escape following adoptive T cell therapy","volume":"129","author":"Walsh","year":"2019","journal-title":"J Clin Invest."},{"issue":"11","key":"10.1016\/j.intimp.2025.115876_bb0845","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc3106","article-title":"RAS oncogenes: weaving a tumorigenic web","volume":"11","author":"Pylayeva-Gupta","year":"2011","journal-title":"Nat Rev Cancer."},{"issue":"5","key":"10.1016\/j.intimp.2025.115876_bb0850","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1021\/acsnano.9b00892","article-title":"Engineering Magnetosomes for Ferroptosis\/Immunomodulation Synergism in Cancer","volume":"13","author":"Zhang","year":"2019","journal-title":"ACS Nano."},{"issue":"13","key":"10.1016\/j.intimp.2025.115876_bb0855","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay9789","article-title":"Irradiated tumor cell-derived microparticles mediate tumor eradication via cell killing and immune reprogramming","volume":"6","author":"Wan","year":"2020","journal-title":"Sci Adv."},{"issue":"3","key":"10.1016\/j.intimp.2025.115876_bb0860","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41589-019-0462-8","article-title":"Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death","volume":"16","author":"Kapralov","year":"2020","journal-title":"Nat Chem Biol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115876_bb0865","doi-asserted-by":"crossref","DOI":"10.1128\/mcb.00522-21","article-title":"Mechanism of Erastin-Induced Ferroptosis in MDA-MB-231 Human Breast Cancer Cells: Evidence for a Critical Role of Protein Disulfide Isomerase","volume":"42","author":"Wang","year":"2022","journal-title":"Mol Cell Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0870","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/med.21599","article-title":"Inducible nitric oxide synthase: Regulation, structure, and inhibition","volume":"40","author":"Cinelli","year":"2020","journal-title":"Med Res Rev."},{"issue":"6","key":"10.1016\/j.intimp.2025.115876_bb0875","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/s41418-020-00719-2","article-title":"Oxygenated phosphatidylethanolamine navigates phagocytosis of ferroptotic cells by interacting with TLR2","volume":"28","author":"Luo","year":"2021","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0880","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13045-021-01156-5","article-title":"Modulating tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor response","volume":"14","author":"Park","year":"2021","journal-title":"J Hematol Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115876_bb0885","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/2326-6066.CIR-20-0384","article-title":"Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8(+) T Cells","volume":"9","author":"Drijvers","year":"2021","journal-title":"Cancer Immunol Res."},{"issue":"4","key":"10.1016\/j.intimp.2025.115876_bb0890","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrc3246","article-title":"The determinants of tumour immunogenicity","volume":"12","author":"Blankenstein","year":"2012","journal-title":"Nat Rev Cancer."},{"issue":"9","key":"10.1016\/j.intimp.2025.115876_bb0895","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1016\/j.celrep.2019.10.070","article-title":"B1 and Marginal Zone B Cells but Not Follicular B2 Cells Require Gpx4 to Prevent Lipid Peroxidation and Ferroptosis","volume":"29","author":"Muri","year":"2019","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.intimp.2025.115876_bb0900","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1084\/jem.20140857","article-title":"T cell lipid peroxidation induces ferroptosis and prevents immunity to infection","volume":"212","author":"Matsushita","year":"2015","journal-title":"J Exp Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.115876_bb0905","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41374-017-0008-1","article-title":"Glutathione peroxidase 4 overexpression inhibits ROS-induced cell death in diffuse large B-cell lymphoma","volume":"98","author":"Kinowaki","year":"2018","journal-title":"Lab Invest."},{"issue":"6","key":"10.1016\/j.intimp.2025.115876_bb0910","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1179\/135100010X12826446921707","article-title":"Scavenging of reactive oxygen and nitrogen species by the prodrug sulfasalazine and its metabolites 5-aminosalicylic acid and sulfapyridine","volume":"15","author":"Couto","year":"2010","journal-title":"Redox Rep."},{"key":"10.1016\/j.intimp.2025.115876_bb0915","doi-asserted-by":"crossref","first-page":"224","DOI":"10.18632\/oncotarget.28185","article-title":"Impact of the glutathione synthesis pathway on sulfasalazine-treated endometrial cancer","volume":"13","author":"Sendo","year":"2022","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0920","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2015.07.031","article-title":"Xc- inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism","volume":"368","author":"Ma","year":"2015","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.intimp.2025.115876_bb0925","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.3892\/ol.2020.11813","article-title":"xCT inhibitor sulfasalazine depletes paclitaxel-resistant tumor cells through ferroptosis in uterine serous carcinoma","volume":"20","author":"Sugiyama","year":"2020","journal-title":"Oncol Lett."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0930","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1186\/s12885-021-09076-w","article-title":"Identification of immune subtypes of Ph-neg B-ALL with ferroptosis related genes and the potential implementation of Sorafenib","volume":"21","author":"Hong","year":"2021","journal-title":"BMC Cancer."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0935","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13046-022-02296-3","article-title":"Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma","volume":"41","author":"Byun","year":"2022","journal-title":"J Exp Clin Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2025.115876_bb0940","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","article-title":"Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Chem Biol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115876_bb0945","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI124049","article-title":"Suppression of the SLC7A11\/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma","volume":"130","author":"Hu","year":"2020","journal-title":"J Clin Invest."},{"issue":"4","key":"10.1016\/j.intimp.2025.115876_bb0950","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s10616-025-00795-7","article-title":"Dual effects of erastin on aggressive osteosarcoma cells: ferroptosis sensitization and anti-ferroptotic gene activation","volume":"77","author":"Burns","year":"2025","journal-title":"Cytotechnology"},{"issue":"8","key":"10.1016\/j.intimp.2025.115876_bb0955","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/1878-0261.12936","article-title":"Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS-mitochondrial fission-mitophagy axis","volume":"15","author":"Liu","year":"2021","journal-title":"Mol Oncol."},{"issue":"21","key":"10.1016\/j.intimp.2025.115876_bb0960","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1016\/j.bmcl.2015.07.018","article-title":"Incorporation of metabolically stable ketones into a small molecule probe to increase potency and water solubility","volume":"25","author":"Larraufie","year":"2015","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.intimp.2025.115876_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176009","article-title":"Butyrate enhances erastin-induced ferroptosis of osteosarcoma cells via regulating ATF3\/SLC7A11 pathway","volume":"957","author":"Nie","year":"2023","journal-title":"Eur J Pharmacol."},{"key":"10.1016\/j.intimp.2025.115876_bb0970","doi-asserted-by":"crossref","first-page":"1170754","DOI":"10.3389\/fimmu.2023.1170754","article-title":"The roles of ERIANIN in tumor and innate immunity and its' perspectives in immunotherapy","volume":"14","author":"Yang","year":"2023","journal-title":"Front Immunol."},{"issue":"23","key":"10.1016\/j.intimp.2025.115876_bb0975","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1177\/15353702231220670","article-title":"Curcumin induces ferroptosis and apoptosis in osteosarcoma cells by regulating Nrf2\/GPX4 signaling pathway","volume":"248","author":"Yuan","year":"2023","journal-title":"Exp Biol Med (Maywood)."},{"issue":"5","key":"10.1016\/j.intimp.2025.115876_bb0980","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The Role of Non-coding RNAs in Oncology","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.115876_bb0985","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.816460","article-title":"Identification of an Iron Metabolism-Related lncRNA Signature for Predicting Osteosarcoma Survival and Immune Landscape","volume":"13","author":"Hong-Bin","year":"2022","journal-title":"Front Genet."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb0990","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s40001-023-01309-x","article-title":"Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance","volume":"28","author":"Qin","year":"2023","journal-title":"Eur J Med Res."},{"issue":"5","key":"10.1016\/j.intimp.2025.115876_bb0995","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrg.2016.20","article-title":"Endogenous microRNA sponges: evidence and controversy","volume":"17","author":"Thomson","year":"2016","journal-title":"Nat Rev Genet."},{"key":"10.1016\/j.intimp.2025.115876_bb1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108695","article-title":"LncRNA SNHG3\/miRNA-151a-3p\/RAB22A axis regulates invasion and migration of osteosarcoma","volume":"112","author":"Zheng","year":"2019","journal-title":"Biomed Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb1005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12943-018-0837-6","article-title":"Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma","volume":"17","author":"Wang","year":"2018","journal-title":"Mol Cancer."},{"issue":"5","key":"10.1016\/j.intimp.2025.115876_bb1010","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41417-022-00581-z","article-title":"LncSNHG14 promotes nutlin3a resistance by inhibiting ferroptosis via the miR-206 \/SLC7A11 axis in osteosarcoma cells","volume":"30","author":"Li","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.intimp.2025.115876_bb1015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2023.100490","article-title":"MAT2A inhibits the ferroptosis in osteosarcoma progression regulated by miR-26b-5p","volume":"41","author":"Xia","year":"2023","journal-title":"J Bone Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115876_bb1020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41388-023-02882-5","article-title":"M(7)G modification of FTH1 and pri-miR-26a regulates ferroptosis and chemotherapy resistance in osteosarcoma","volume":"43","author":"He","year":"2024","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.intimp.2025.115876_bb1025","doi-asserted-by":"crossref","DOI":"10.3892\/or.2023.8629","article-title":"Circular RNA circBLNK promotes osteosarcoma progression and inhibits ferroptosis in osteosarcoma cells by sponging miR-188-3p and regulating GPX4 expression","volume":"50","author":"Li","year":"2023","journal-title":"Oncol Rep."},{"issue":"11","key":"10.1016\/j.intimp.2025.115876_bb1030","first-page":"1758","article-title":"A novel ferroptosis-related microRNA signature with prognostic value in osteosarcoma","volume":"55","author":"Shao","year":"2023","journal-title":"Acta Biochim Biophys Sin (Shanghai)."},{"issue":"19","key":"10.1016\/j.intimp.2025.115876_bb1035","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.18632\/aging.102325","article-title":"LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p\/MBTD1 axis","volume":"11","author":"Fu","year":"2019","journal-title":"Aging (Albany NY)."},{"key":"10.1016\/j.intimp.2025.115876_bb1040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.canlet.2017.03.018","article-title":"Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2","volume":"396","author":"Zhang","year":"2017","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.intimp.2025.115876_bb1045","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.prp.2018.12.013","article-title":"lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET\/PI3K\/AKT pathway","volume":"215","author":"Sun","year":"2019","journal-title":"Pathol Res Pract."},{"issue":"2","key":"10.1016\/j.intimp.2025.115876_bb1050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.canlet.2015.06.003","article-title":"Circular RNA: A new star of noncoding RNAs","volume":"365","author":"Qu","year":"2015","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.intimp.2025.115876_bb1055","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/15476286.2016.1271524","article-title":"Insights into circular RNA biology","volume":"14","author":"Ebbesen","year":"2017","journal-title":"RNA Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb1060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41568-020-00306-0","article-title":"RNA in cancer","volume":"21","author":"Goodall","year":"2021","journal-title":"Nat Rev Cancer."},{"issue":"4","key":"10.1016\/j.intimp.2025.115876_bb1065","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cell.2018.12.021","article-title":"The Landscape of Circular RNA in Cancer","volume":"176","author":"Vo","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.115876_bb1070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pharmthera.2018.01.010","article-title":"Circular RNA and its mechanisms in disease: From the bench to the clinic","volume":"187","author":"Han","year":"2018","journal-title":"Pharmacol Ther."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb1075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s10020-020-00159-1","article-title":"Wang, circKIF4A promotes tumorogenesis of glioma by targeting miR-139-3p to activate Wnt5a signaling","volume":"26","author":"Huo","year":"2020","journal-title":"Mol Med."},{"issue":"18","key":"10.1016\/j.intimp.2025.115876_bb1080","doi-asserted-by":"crossref","first-page":"17921","DOI":"10.18632\/aging.103389","article-title":"circKIF4A sponges miR-127 to promote ovarian cancer progression","volume":"12","author":"Sheng","year":"2020","journal-title":"Aging (Albany NY)."},{"key":"10.1016\/j.intimp.2025.115876_bb1085","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3389\/fphar.2020.00605","article-title":"Circular RNA circKIF4A Sponges miR-375\/1231 to Promote Bladder Cancer Progression by Upregulating NOTCH2 Expression","volume":"11","author":"Shi","year":"2020","journal-title":"Front Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb1090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12943-019-0946-x","article-title":"Xie, circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer","volume":"18","author":"Tang","year":"2019","journal-title":"Mol Cancer."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb1095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13000-020-00963-7","article-title":"Circular RNA KIF4A promotes cell migration, invasion and inhibits apoptosis through miR-152\/ZEB1 axis in breast cancer","volume":"15","author":"Jin","year":"2020","journal-title":"Diagn Pathol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115876_bb1100","doi-asserted-by":"crossref","first-page":"16500","DOI":"10.18632\/aging.203172","article-title":"Circular RNA circKIF4A facilitates the malignant progression and suppresses ferroptosis by sponging miR-1231 and upregulating GPX4 in papillary thyroid cancer","volume":"13","author":"Chen","year":"2021","journal-title":"Aging (Albany NY)."},{"issue":"6","key":"10.1016\/j.intimp.2025.115876_bb1105","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1007\/s11033-022-07296-2","article-title":"CircKIF4A enhances osteosarcoma proliferation and metastasis by sponging MiR-515-5p and upregulating SLC7A11","volume":"49","author":"He","year":"2022","journal-title":"Mol Biol Rep."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb1110","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1080\/10717544.2022.2141921","article-title":"Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma in vitro and in vivo","volume":"29","author":"Wang","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.intimp.2025.115876_bb1115","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111592","article-title":"Dual-functional scaffolds of poly(L-lactic acid)\/nanohydroxyapatite encapsulated with metformin: Simultaneous enhancement of bone repair and bone tumor inhibition","volume":"120","author":"Tan","year":"2021","journal-title":"Mater Sci Eng C Mater Biol Appl."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb1120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12951-023-01826-1","article-title":"Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics","volume":"21","author":"Shi","year":"2023","journal-title":"J Nanobiotechnology."},{"key":"10.1016\/j.intimp.2025.115876_bb1125","first-page":"207","article-title":"A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis","volume":"10","author":"Cui","year":"2022","journal-title":"Bioact Mater."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb1130","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s12951-023-02129-1","article-title":"Bone-targeting exosome nanoparticles activate Keap1 \/ Nrf2 \/ GPX4 signaling pathway to induce ferroptosis in osteosarcoma cells","volume":"21","author":"Chen","year":"2023","journal-title":"J Nanobiotechnology."},{"key":"10.1016\/j.intimp.2025.115876_bb1135","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107611","article-title":"New insights into molecular and cellular mechanisms of zoledronate in human osteosarcoma","volume":"214","author":"Lu","year":"2020","journal-title":"Pharmacol Ther."},{"key":"10.1016\/j.intimp.2025.115876_bb1140","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jconrel.2022.06.019","article-title":"A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy","volume":"348","author":"Hu","year":"2022","journal-title":"J Control Release."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb1145","article-title":"Reversing ferroptosis resistance by MOFs through regulation intracellular redox homeostasis, Asian","volume":"18","author":"Wang","year":"2023","journal-title":"J Pharm Sci."},{"issue":"4","key":"10.1016\/j.intimp.2025.115876_bb1150","first-page":"475","article-title":"Development of nanoscale drug delivery systems of dihydroartemisinin for cancer therapy: A review","volume":"17","author":"Wong","year":"2022","journal-title":"Asian J Pharm Sci."},{"issue":"3","key":"10.1016\/j.intimp.2025.115876_bb1155","doi-asserted-by":"crossref","DOI":"10.3390\/gels11030207","article-title":"Smart Poly(N-isopropylacrylamide)-Based Hydrogels: A Tour D'horizon of Biomedical Applications","volume":"11","author":"Narayana","year":"2025","journal-title":"Gels"},{"issue":"16","key":"10.1016\/j.intimp.2025.115876_bb1160","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2217\/nnm-2022-0064","article-title":"Synergistic chemo-photothermal and ferroptosis therapy of polydopamine nanoparticles for esophageal cancer","volume":"17","author":"Chen","year":"2022","journal-title":"Nanomedicine (Lond)."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb1165","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1080\/10717544.2022.2059124","article-title":"Manganese-containing polydopamine nanoparticles as theranostic agents for magnetic resonance imaging and photothermal\/chemodynamic combined ferroptosis therapy treating gastric cancer","volume":"29","author":"Chen","year":"2022","journal-title":"Drug Deliv."},{"issue":"21","key":"10.1016\/j.intimp.2025.115876_bb1170","doi-asserted-by":"crossref","first-page":"24089","DOI":"10.1021\/acsami.2c00574","article-title":"Chemodynamic and Photothermal Combination Therapy Based on Dual-Modified Metal-Organic Framework for Inducing Tumor Ferroptosis\/Pyroptosis","volume":"14","author":"Deng","year":"2022","journal-title":"ACS Appl Mater Interfaces."},{"issue":"3","key":"10.1016\/j.intimp.2025.115876_bb1175","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.nantod.2012.04.002","article-title":"Guided Delivery of Polymer Therapeutics Using Plasmonic Photothermal Therapy","volume":"7","author":"Gormley","year":"2012","journal-title":"Nano Today."},{"issue":"21","key":"10.1016\/j.intimp.2025.115876_bb1180","article-title":"Tumor Customized 2D Supramolecular Nanodiscs for Ultralong Tumor Retention and Precise Photothermal Therapy of Highly Heterogeneous Cancers","volume":"18","author":"Lin","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.intimp.2025.115876_bb1185","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121383","article-title":"Photothermal-triggered immunogenic nanotherapeutics for optimizing osteosarcoma therapy by synergizing innate and adaptive immunity","volume":"282","author":"Liu","year":"2022","journal-title":"Biomaterials"},{"issue":"31","key":"10.1016\/j.intimp.2025.115876_bb1190","doi-asserted-by":"crossref","first-page":"35454","DOI":"10.1021\/acsami.2c11706","article-title":"A Small-Molecule Based Organic Nanoparticle for Photothermal Therapy and Near-Infrared-IIb Imaging","volume":"14","author":"Lou","year":"2022","journal-title":"ACS Appl Mater Interfaces."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb1195","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40824-022-00275-5","article-title":"Manganese-based hollow nanoplatforms for MR imaging-guided cancer therapies","volume":"26","author":"Liang","year":"2022","journal-title":"Biomater Res."},{"key":"10.1016\/j.intimp.2025.115876_bb1200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijbiomac.2021.04.053","article-title":"Rice starch coated iron oxide nanoparticles: A theranostic probe for photoacoustic imaging-guided photothermal cancer therapy","volume":"183","author":"Vo","year":"2021","journal-title":"Int J Biol Macromol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115876_bb1205","doi-asserted-by":"crossref","first-page":"10001","DOI":"10.1021\/acsami.1c20416","article-title":"A Nanoarchitectonic Approach Enables Triple Modal Synergistic Therapies To Enhance Antitumor Effects","volume":"14","author":"Mo","year":"2022","journal-title":"ACS Appl Mater Interfaces."},{"issue":"23","key":"10.1016\/j.intimp.2025.115876_bb1210","doi-asserted-by":"crossref","first-page":"12971","DOI":"10.1002\/anie.202101924","article-title":"Single-Atom Pd Nanozyme for Ferroptosis-Boosted Mild-Temperature Photothermal Therapy","volume":"60","author":"Chang","year":"2021","journal-title":"Angew Chem Int Ed Engl."},{"issue":"6","key":"10.1016\/j.intimp.2025.115876_bb1215","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1039\/D0TB02659J","article-title":"Polymeric photothermal agents for cancer therapy: recent progress and clinical potential","volume":"9","author":"Du","year":"2021","journal-title":"J Mater Chem B."},{"issue":"13","key":"10.1016\/j.intimp.2025.115876_bb1220","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202112925","article-title":"Coordinating the Mechanisms of Action of Ferroptosis and the Photothermal Effect for Cancer Theranostics","volume":"61","author":"Zeng","year":"2022","journal-title":"Angew Chem Int Ed Engl."},{"issue":"12","key":"10.1016\/j.intimp.2025.115876_bb1225","article-title":"Magnetic Silica-Coated Iron Oxide Nanochains as Photothermal Agents, Disrupting the Extracellular","volume":"11","author":"Kolosnjaj-Tabi","year":"2019","journal-title":"Matrix"},{"issue":"42","key":"10.1016\/j.intimp.2025.115876_bb1230","doi-asserted-by":"crossref","first-page":"8882","DOI":"10.1039\/D1TB01629F","article-title":"Development of copper vacancy defects in a silver-doped CuS nanoplatform for high-efficiency photothermal-chemodynamic synergistic antitumor therapy","volume":"9","author":"Qin","year":"2021","journal-title":"J Mater Chem B."},{"issue":"48","key":"10.1016\/j.intimp.2025.115876_bb1235","doi-asserted-by":"crossref","first-page":"53501","DOI":"10.1021\/acsami.2c15495","article-title":"Photodynamic Therapy Initiated Ferrotherapy of Self-Delivery Nanomedicine to Amplify Lipid Peroxidation via GPX4 Inactivation","volume":"14","author":"Zhao","year":"2022","journal-title":"ACS Appl Mater Interfaces."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb1240","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12936","article-title":"An update on the roles of circular RNAs in osteosarcoma","volume":"54","author":"Li","year":"2021","journal-title":"Cell Prolif."},{"issue":"5","key":"10.1016\/j.intimp.2025.115876_bb1245","doi-asserted-by":"crossref","first-page":"20220141","DOI":"10.1002\/EXP.20220141","article-title":"Small-molecule nanoprodrug with high drug loading and EGFR, PI3K\/AKT dual-inhibiting properties for bladder cancer treatment","volume":"3","author":"Li","year":"2023","journal-title":"Exploration (Beijing)."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb1250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40824-022-00308-z","article-title":"Recent advances in near-infrared-II hollow nanoplatforms for photothermal-based cancer treatment","volume":"26","author":"Zhang","year":"2022","journal-title":"Biomater Res."},{"key":"10.1016\/j.intimp.2025.115876_bb1255","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jconrel.2022.12.037","article-title":"Applications of polydopaminic nanomaterials in mucosal drug delivery","volume":"353","author":"Bedhiafi","year":"2023","journal-title":"J Control Release."},{"key":"10.1016\/j.intimp.2025.115876_bb1260","article-title":"Polydopamine, harness of the antibacterial potentials-A review","volume":"15","author":"He","year":"2022","journal-title":"Mater Today Bio."},{"issue":"3","key":"10.1016\/j.intimp.2025.115876_bb1265","first-page":"522","article-title":"Nanoparticles modified by polydopamine: Working as \"drug\" carriers","volume":"5","author":"Jin","year":"2020","journal-title":"Bioact Mater."},{"issue":"12","key":"10.1016\/j.intimp.2025.115876_bb1270","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1038\/s41596-022-00718-2","article-title":"MOF-derived nanoporous carbons with diverse tunable nanoarchitectures","volume":"17","author":"Kim","year":"2022","journal-title":"Nat Protoc."},{"key":"10.1016\/j.intimp.2025.115876_bb1275","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jcis.2021.12.071","article-title":"Multifunctional phototheranostic nanoplatform based on polydopamine-manganese dioxide-IR780 iodide for effective magnetic resonance imaging-guided synergistic photodynamic\/photothermal therapy","volume":"611","author":"Mo","year":"2022","journal-title":"J Colloid Interface Sci."},{"issue":"42","key":"10.1016\/j.intimp.2025.115876_bb1280","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1039\/D2TB01691E","article-title":"MOF(Fe)-derived composites as a unique nanoplatform for chemo-photodynamic tumor therapy","volume":"10","author":"Mo","year":"2022","journal-title":"J Mater Chem B."},{"issue":"7","key":"10.1016\/j.intimp.2025.115876_bb1285","article-title":"Progress and Prospects of Electrochemiluminescence Biosensors Based on Porous Nanomaterials","volume":"12","author":"Li","year":"2022","journal-title":"Biosensors (Basel)."},{"key":"10.1016\/j.intimp.2025.115876_bb1290","first-page":"157","article-title":"A multifunctional biomimetic nanoplatform for image-guideded photothermal-ferroptotic synergistic osteosarcoma therapy","volume":"36","author":"Liu","year":"2024","journal-title":"Bioact Mater."},{"issue":"2","key":"10.1016\/j.intimp.2025.115876_bb1295","doi-asserted-by":"crossref","first-page":"18","DOI":"10.33545\/26646552.2025.v7.i2a.92","article-title":"Green synthesis of nanoparticles and their biomedical implications: An eco-chemical perspective","volume":"7","author":"Anjali","year":"2025","journal-title":"International Journal of Chemical Research and Development."},{"issue":"1","key":"10.1016\/j.intimp.2025.115876_bb1300","doi-asserted-by":"crossref","first-page":"28","DOI":"10.33696\/Nanotechnol.6.061","article-title":"Nanoscale Diagnosis and Therapy Nanotheranostics as an Advance in Nanotechnology","volume":"6","author":"Backx","year":"2025","journal-title":"Journal of Nanotechnology and Nanomaterials."},{"key":"10.1016\/j.intimp.2025.115876_bb1305","first-page":"329","article-title":"Phytoconstituent-Based Green Synthesis of Nanoparticles","volume":"9","author":"Reddy","year":"2025","journal-title":"Asian Journal of Green Chemistry"},{"issue":"2","key":"10.1016\/j.intimp.2025.115876_bb1310","first-page":"191","article-title":"Biochemical Engineering of Green Nanomaterials for Targeted Drug Delivery and Therapeutic Applications, Journal of","volume":"7","author":"Kumar","year":"2025","journal-title":"Chemical Reviews."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925018648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925018648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:57:30Z","timestamp":1773899850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925018648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":262,"alternative-id":["S1567576925018648"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115876","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amino acid transporter SLC7A11 functions in ferroptosis regulation and immune microenvironment in osteosarcoma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115876"}}